Traumatic Brain Injury: Preclinical Imaging Diagnostic(s) and Therapeutic Approaches

Author(s): Eric L. Kaijzel*, Ermond R. van Beek, Marieke A. Stammes, Ivo Que, Alan B. Chan, Clemens W.G.M. Lowik, Luis J. Cruz.

Journal Name: Current Pharmaceutical Design

Volume 23 , Issue 13 , 2017

Abstract:

Background: Traumatic brain injury (TBI) is the result of an external physical force to the head that harms the brain. TBI is a major public health problem worldwide and mainly results from falls, vehicle accidents and violence.

Clinical problem: The management of TBI, causing a wide spectrum of possible health outcomes, has barely changed over the years as encouraging outcomes from many pre-clinical therapeutic and pharmacological studies have only rarely been translated to the clinical situation.

New management options: In the last decades management of TBI is rapidly advancing and new innovative imaging modalities with sophisticated treatment options by using nanomedicine based drug delivery systems are under investigation. Nano formulations such as PLGA, exosomes and liposomes have the advantage of a targeted and controlled delivery of their cargo, such as diagnostic probes and/or therapeutic drugs.

Summary: Here we provide an overview of new promising pre-clinical developments in TBI management that may find their way to the clinic in the near future. Nanotechnology and nanomedicine in TBI intervention may establish new platforms for targeted drug delivery to the traumatized brain to improve the quality of life and survival of TBI patients.

Keywords: Traumatic brain injury, molecular imaging, nanoparticles, mouse model, probes.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 23
ISSUE: 13
Year: 2017
Page: [1909 - 1915]
Pages: 7
DOI: 10.2174/1381612823666170116141116

Article Metrics

PDF: 25
HTML: 3
EPUB: 1
PRC: 1